Search by Drug Name or NDC
NDC 61825-0305-60 Norgesic 385; 30; 25 mg/1; mg/1; mg/1 Details
Norgesic 385; 30; 25 mg/1; mg/1; mg/1
Norgesic is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Galt Pharmaceuticals, LLC. The primary component is ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE.
Product Information
NDC | 61825-0305 |
---|---|
Product ID | 61825-305_0e7bccb0-630c-9661-e063-6394a90a29e9 |
Associated GPIs | 75990003200310 |
GCN Sequence Number | 004311 |
GCN Sequence Number Description | orphenadrine/aspirin/caffeine TABLET 25-385-30 ORAL |
HIC3 | H6H |
HIC3 Description | SKELETAL MUSCLE RELAXANTS |
GCN | 71190 |
HICL Sequence Number | 001791 |
HICL Sequence Number Description | ORPHENADRINE CITRATE/ASPIRIN/CAFFEINE |
Brand/Generic | Generic |
Proprietary Name | Norgesic |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Orphenadrine Citrate, Aspirin and Caffeine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 385; 30; 25 |
Active Ingredient Units | mg/1; mg/1; mg/1 |
Substance Name | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE |
Labeler Name | Galt Pharmaceuticals, LLC |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prost |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075141 |
Listing Certified Through | 2025-12-31 |
Package
NDC 61825-0305-60 (61825030560)
NDC Package Code | 61825-305-60 |
---|---|
Billing NDC | 61825030560 |
Package | 60 TABLET in 1 BOTTLE, PLASTIC (61825-305-60) |
Marketing Start Date | 2022-05-16 |
NDC Exclude Flag | N |
Pricing Information | N/A |